Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease.

The effect was significant in the pre-treatment paradigm but was less robust and did not reach statistical significance in the post-treatment paradigm ( Figure 5a , last 5 rows).

also in 111,027 other papers